Lilly is the maker of tirzepatide, a drug sold under the name Mounjaro for type 2 diabetes and as Zepbound for weight loss. These injectable drugs, along with the recently approved oral weight loss …
After Eli Lilly’s Explosive Earnings Report, Is It Too Late to Buy the Stock?
view original post